Thomas Briggs brings 20 years of commercial development experience in biotechnology and large medical diagnostic companies to YourBio Health, including extensive experience in molecular diagnostic development, product applications, and partnership development.
Prior to YourBio, Mr. Briggs led Becton Dickinson’s external collaboration and partnerships for the Emerging Specimen Management Business Line. In this capacity, he was responsible for business development activities and marketing strategy, including the launch of multiple specialty blood collection products. Additionally, he served as a subject matter expert within the blood micro sampling space as a workstream lead within the IHI Project Comfort for demonstrating clinical validity of home collected blood samples.
Between 2013 and 2021, Mr. Briggs held various business-development related positions both at Becton Dickinson and Tempus Labs focused on cultivating and growing partnerships with pharmaceutical and biotechnology clients to support them in advancing their research, clinical and/or commercial programs.
Before joining Becton Dickinson in 2013, Mr. Briggs spent 10 years in IVD Diagnostic Development with three of the top 10 Global Diagnostic companies: Abbott (Abbvie), BioMerieux and Johnson & Johnson. These roles resulted in 4 patents, 6 publications in Molecular Diagnostics along with leading a development program to replace charcoal with antibiotic binding resin in blood culture bottles.
Mr. Briggs holds a master’s degree in Marketing and Management (MBA) from DeSales University, a master’s degree in Molecular Biology from East Stroudsburg University, a bachelor’s degree in Biological Science from Pennsylvania State University and an NIH NCI Cancer Research Fellowship.
Back to Our Team